Dr Sam Oddie Sam Oddie, co-Chief Investigator of Prevail Trial presenting this very important trial’s results at #EAPS2018 today.

#NeoEBM Sam Oddie great to see the PREVAIL trial published - 861 infants randomised, no evidence of benefit with miconazole and rifampicin-impregnated peripherally inserted central venous lines compared with standard lines in (mainly preterm) infants receiving neonatal care

Our June issue is out! This month, we feature Prevail Trial, defining health risk in #ChildhoodObesity, reducing distress related to #NGtube insertion, human #bocaviruses and infections, & more! Read now 👉 ow.ly/eJhs50u6mwF

Thanks for the review NeonatalResearch! While it can feel disappointing not to see a positive intervention effect, Dr Barrington's blog post summarising our results discusses how important it is to have good quality evidence either way... "this is exactly why RCTs PREVAIL"

Why not share your photos of #WhyWeDoResearch and what clinical research means to you with the @OfficialNIHR ? #NIHRgetdigital #IAmResearch x.com/OfficialNIHR/s…

Congratulations on opening ARCTIC - great to have more trials working to reduce risk of bloodstream infections in preterm babies x.com/ARCTIC_Trial/s…

July is here & any #PrevailBabies still in hospital will finish follow-up this month. Looking forward to data lock & starting the analysis!

Our sites might recognise this... A very Prevail wedding present for our Trial Coordinator - thanks Sam Oddie !

It's been a whole year since we closed to recruitment, follow-up finished in July, all data has now been returned, cleaned and we're about to lock the database and start analysis! Looking forward to having results and hopefully improving outcomes for vulnerable babies very soon.